Paper7929454
N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.
Platt FM and 4 others. J Biol Chem, 1994. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing. Papers, record 7929454. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7929454
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 1-Deoxynojirimycin | Major topic |
| Glycolipids | Major topic |
| Oligosaccharides | Major topic |
| Animals | |
| Cells, Cultured | |
| Disease Models, Animal | |
| Gaucher Disease | |
| Glucosylceramidase | |
| Glucosyltransferases | |
| Humans | |
| Mice | |
| Structure-Activity Relationship | |
| alpha-Glucosidases |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00194649 | Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study (MIG 2) | Background |
Source ClinicalTrials.gov
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353206 | Off-Target Binding of Miglustat to Glycogen Debranching Enzyme. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353206 | PubMed |
| 38737101 | Therapeutic developments for neurodegenerative GM1 gangliosidosis. | Front Neurosci | 2024 | https://conductscience.org/library/papers/38737101 | PubMed |
| 37622990 | Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands. | Glycobiology | 2023 | https://conductscience.org/library/papers/37622990 | PubMed |
| 34445564 | Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445564 | PubMed |
| 33304924 | CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/33304924 | PubMed |
| 32768411 | Iminosugars: A host-targeted approach to combat Flaviviridae infections. | Antiviral Res | 2020 | https://conductscience.org/library/papers/32768411 | PubMed |
| 32219518 | The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis. | Hum Genet | 2020 | https://conductscience.org/library/papers/32219518 | PubMed |
| 32083331 | Developments in the treatment of Fabry disease. | J Inherit Metab Dis | 2020 | https://conductscience.org/library/papers/32083331 | PubMed |
| 30917945 | Approaches for probing and evaluating mammalian sphingolipid metabolism. | Anal Biochem | 2019 | https://conductscience.org/library/papers/30917945 | PubMed |
| 30060815 | Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era. | Adv Cancer Res | 2018 | https://conductscience.org/library/papers/30060815 | PubMed |
| 28975712 | Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2. | ChemMedChem | 2017 | https://conductscience.org/library/papers/28975712 | PubMed |
| 28088251 | Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects. | Orphanet J Rare Dis | 2017 | https://conductscience.org/library/papers/28088251 | PubMed |
| 27916601 | Gaucher disease: Progress and ongoing challenges. | Mol Genet Metab | 2017 | https://conductscience.org/library/papers/27916601 | PubMed |
| 27638604 | New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones. | J Neurosci Res | 2016 | https://conductscience.org/library/papers/27638604 | PubMed |
| 27384562 | Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27384562 | PubMed |
| 26974655 | Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes. | PLoS Negl Trop Dis | 2016 | https://conductscience.org/library/papers/26974655 | PubMed |
| 26946111 | Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4. | Antiviral Res | 2016 | https://conductscience.org/library/papers/26946111 | PubMed |
| 26771826 | Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease. | PLoS One | 2016 | https://conductscience.org/library/papers/26771826 | PubMed |
| 26095364 | Complexity and Diversity of the Mammalian Sialome Revealed by Nidovirus Virolectins. | Cell Rep | 2015 | https://conductscience.org/library/papers/26095364 | PubMed |
| 25141135 | GBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa. | PLoS One | 2014 | https://conductscience.org/library/papers/25141135 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| UGCG | 7357 | PubTator's text mining | https://conductscience.org/library/genes/7357 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7929454
GET https://conductscience.org/api/papers/v1/7929454/cited_by?page=2